Corxel Pharmaceuticals Co. Ltd.

Corxel Pharmaceuticals Co. Ltd. is engaged in clinical research centered on acute ischemic stroke, with a focus on neurological recovery and post-stroke functional outcomes. The sponsor’s current trial activity reflects interest in treatment approaches for patients affected by sudden cerebral blood flow interruption.

• Functional recovery
• Modified Rankin Scale outcomes
• Neurologic function

Research activity in this area also includes evaluation of safety considerations relevant to stroke care, including the risk of symptomatic intracranial hemorrhage.